Author:
Jiang Jie-Long,Ren Wei,Li Yan,Liu Guang-Yi,Zhou Cai-Ping,Su Ke-Liang,Chen Wei,Wang Ke,Ni Li-Jun,Hu Zhao
Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM (2004) Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15:2208–2218
2. Palmer SC, Hayen A, Macaskill P, Pellegrini F, Craig JC, Elder GJ, Strippoli GF (2011) Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis. JAMA 305:1119–1127
3. Floege J, Kim J, Ireland E, Chazot C, Drueke T, de Francisco A, Kronenberg F, Marcelli D, Passlick-Deetjen J, Schernthaner G, Fouqueray B, Wheeler DC (2011) Serum ipth, calcium and phosphate, and the risk of mortality in a european haemodialysis population. Nephrol Dial Transplant 26:1948–1955
4. Capuano A, Serio V, Pota A, Memoli B, Andreucci VE (2009) Beneficial effects of better control of secondary hyperparathyroidism with paricalcitol in chronic dialysis patients. J Nephrol 22:59–68
5. Lin CL, Hung CC, Yang CT, Huang CC (2004) Improved anemia and reduced erythropoietin need by medical or surgical intervention of secondary hyperparathyroidism in hemodialysis patients. Ren Fail 26:289–295
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献